{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T14:31:37Z","timestamp":1780410697187,"version":"3.54.1"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,11,28]]},"DOI":"10.1097\/qad.0b013e32835a117c","type":"journal-article","created":{"date-parts":[[2012,9,26]],"date-time":"2012-09-26T16:41:49Z","timestamp":1348677709000},"page":"2327-2335","source":"Crossref","is-referenced-by-count":103,"title":["Cerebral \u03b2-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE \u03b54 carriers"],"prefix":"10.1097","volume":"26","author":[{"given":"Virawudh","family":"Soontornniyomkij","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Gouaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benchawanna","family":"Soontornniyomkij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erick T.","family":"Tatro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anya","family":"Umlauf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliezer","family":"Masliah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyse J.","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry V.","family":"Vinters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin B.","family":"Gelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Morgello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Cherner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian L.","family":"Achim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210130","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s13365-010-0006-1","article-title":"HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors.","volume":"17","author":"Heaton","year":"2011","journal-title":"J Neurovirol"},{"key":"R2-7-20210130","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/09540260701861930","article-title":"Evolution of HIV dementia with HIV infection.","volume":"20","author":"Nath","year":"2008","journal-title":"Int Rev Psychiatry"},{"key":"R3-7-20210130","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11481-009-9154-6","article-title":"Host and viral factors influencing the pathogenesis of HIV-associated neurocognitive disorders.","volume":"4","author":"Jayadev","year":"2009","journal-title":"J Neuroimmune Pharmacol"},{"key":"R4-7-20210130","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00002030-200501280-00004","article-title":"HIV-1 Tat inhibits neprilysin and elevates amyloid beta.","volume":"19","author":"Rempel","year":"2005","journal-title":"AIDS"},{"key":"R5-7-20210130","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/jnnp.65.1.29","article-title":"Prevalence of Alzheimer plaques in AIDS.","volume":"65","author":"Esiri","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R6-7-20210130","first-page":"175","article-title":"Vasculopathy and amyloid beta reactivity in brains of patients with acquired immune deficiency (AIDS).","volume":"38","author":"Izycka-Swieszewska","year":"2000","journal-title":"Folia Neuropathol"},{"key":"R7-7-20210130","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s11481-009-9152-8","article-title":"Increased accumulation of intraneuronal amyloid beta in HIV-infected patients.","volume":"4","author":"Achim","year":"2009","journal-title":"J Neuroimmune Pharmacol"},{"key":"R8-7-20210130","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/01.aids.0000161770.06158.5c","article-title":"Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients.","volume":"19","author":"Green","year":"2005","journal-title":"AIDS"},{"key":"R9-7-20210130","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00401-006-0037-0","article-title":"Accelerated Tau deposition in the brains of individuals infected with human immunodeficiency virus-1 before and after the advent of highly active antiretroviral therapy.","volume":"111","author":"Anthony","year":"2006","journal-title":"Acta Neuropathol"},{"key":"R10-7-20210130","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1212\/WNL.0b013e3181c5b445","article-title":"CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease.","volume":"73","author":"Clifford","year":"2009","journal-title":"Neurology"},{"key":"R11-7-20210130","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1212\/01.wnl.0000183293.95787.b7","article-title":"CSF amyloid beta42 and tau levels correlate with AIDS dementia complex.","volume":"65","author":"Brew","year":"2005","journal-title":"Neurology"},{"key":"R12-7-20210130","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ana.20730","article-title":"Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.","volume":"59","author":"Fagan","year":"2006","journal-title":"Ann Neurol"},{"key":"R13-7-20210130","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/emmm.200900048","article-title":"Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: implications for future clinical trials of Alzheimers disease.","volume":"1","author":"Fagan","year":"2009","journal-title":"EMBO Mol Med"},{"key":"R14-7-20210130","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1471-2377-9-63","article-title":"Amyloid and tau cerebrospinal fluid biomarkers in HIV infection.","volume":"9","author":"Gisslen","year":"2009","journal-title":"BMC Neurol"},{"key":"R15-7-20210130","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1056\/NEJM199511093331902","article-title":"Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein.","volume":"333","author":"Polvikoski","year":"1995","journal-title":"N Engl J Med"},{"key":"R16-7-20210130","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.21843","article-title":"APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging.","volume":"67","author":"Morris","year":"2010","journal-title":"Ann Neurol"},{"key":"R17-7-20210130","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimers disease in late onset families.","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"R18-7-20210130","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1146\/annurev.genom.1.1.507","article-title":"Apolipoprotein E: far more than a lipid transport protein.","volume":"1","author":"Mahley","year":"2000","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"R19-7-20210130","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.neuron.2009.06.026","article-title":"The role of apolipoprotein E in Alzheimers disease.","volume":"63","author":"Kim","year":"2009","journal-title":"Neuron"},{"key":"R20-7-20210130","doi-asserted-by":"crossref","first-page":"89ra57","DOI":"10.1126\/scitranslmed.3002156","article-title":"Human apoE isoforms differentially regulate brain amyloid- peptide clearance.","volume":"3","author":"Castellano","year":"2011","journal-title":"Sci Transl Med"},{"key":"R21-7-20210130","doi-asserted-by":"crossref","first-page":"E87","DOI":"10.1073\/pnas.0808164105","article-title":"Differential course of HIV-1 infection and APOE polymorphism.","volume":"105","author":"Corder","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R22-7-20210130","doi-asserted-by":"crossref","first-page":"8718","DOI":"10.1073\/pnas.0803526105","article-title":"Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4epsilon4 genotype accelerates HIV disease progression.","volume":"105","author":"Burt","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R24-7-20210130","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1600-0404.1997.tb00217.x","article-title":"HIV dementia and apolipoprotein E.","volume":"95","author":"Dunlop","year":"1997","journal-title":"Acta Neurol Scand"},{"key":"R25-7-20210130","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1468-1293.2008.00614.x","article-title":"The relationship between ApoE, TNFA, IL1a, IL1b and IL12b genes and HIV-1-associated dementia.","volume":"9","author":"Pemberton","year":"2008","journal-title":"HIV Med"},{"key":"R26-7-20210130","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00213-008-1253-1","article-title":"The apolipoprotein E epsilon4 allele and memory performance in HIV-1 seropositive subjects: differences at baseline but not after acute oral lorazepam challenge.","volume":"201","author":"Pomara","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"R27-7-20210130","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1080\/13803390701819036","article-title":"An exploratory study of long-term neurocognitive outcomes following recovery from opportunistic brain infections in HIVadults.","volume":"30","author":"Levine","year":"2008","journal-title":"J Clin Exp Neuropsychol"},{"key":"R28-7-20210130","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1212\/01.WNL.0000287431.88658.8b","article-title":"Updated research nosology for HIV-associated neurocognitive disorders.","volume":"69","author":"Antinori","year":"2007","journal-title":"Neurology"},{"key":"R29-7-20210130","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1176\/ajp.153.9.1195","article-title":"Psychiatric Research Interview for Substance and Mental Disorders (PRISM): reliability for substance abusers.","volume":"153","author":"Hasin","year":"1996","journal-title":"Am J Psychiatry"},{"key":"R30-7-20210130","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archpsyc.1988.01800360017003","article-title":"The Composite International Diagnostic Interview. An epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures.","volume":"45","author":"Robins","year":"1988","journal-title":"Arch Gen Psychiatry"},{"key":"R31-7-20210130","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s13365-011-0076-8","article-title":"Increased cortical expression of FK506 binding protein-51 in HIV-associated neurocognitive disorders.","volume":"18","author":"Soontornniyomkij","year":"2012","journal-title":"J Neurovirol"},{"key":"R32-7-20210130","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00401-009-0532-1","article-title":"Classification and basic pathology of Alzheimer disease.","volume":"118","author":"Duyckaerts","year":"2009","journal-title":"Acta Neuropathol"},{"key":"R33-7-20210130","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/ana.410300503","article-title":"Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study.","volume":"30","author":"Vonsattel","year":"1991","journal-title":"Ann Neurol"},{"key":"R34-7-20210130","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1750-3639.2008.00147.x","article-title":"Staging of neurofibrillary pathology in Alzheimers disease: a study of the BrainNet Europe Consortium.","volume":"18","author":"Alafuzoff","year":"2008","journal-title":"Brain Pathol"},{"key":"R35-7-20210130","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","article-title":"Phases of A beta-deposition in the human brain and its relevance for the development of AD.","volume":"58","author":"Thal","year":"2002","journal-title":"Neurology"},{"key":"R36-7-20210130","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/00005072-199904000-00008","article-title":"Alzheimer neuropathologic alterations in aged cognitively normal subjects.","volume":"58","author":"Davis","year":"1999","journal-title":"J Neuropathol Exp Neurol"},{"key":"R37-7-20210130","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0197-4580(02)00134-3","article-title":"A grading system of Alzheimer disease lesions in neocortical areas.","volume":"24","author":"Metsaars","year":"2003","journal-title":"Neurobiol Aging"},{"key":"R38-7-20210130","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","article-title":"Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years.","volume":"70","author":"Braak","year":"2011","journal-title":"J Neuropathol Exp Neurol"},{"key":"R39-7-20210130","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1212\/WNL.0b013e31824365ab","article-title":"APOE modifies the association between A load and cognition in cognitively normal older adults.","volume":"78","author":"Kantarci","year":"2012","journal-title":"Neurology"},{"key":"R40-7-20210130","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/archneurol.2011.761","article-title":"11C-PiB imaging of human immunodeficiency virus-associated neurocognitive disorder.","volume":"69","author":"Ances","year":"2012","journal-title":"Arch Neurol"},{"key":"R42-7-20210130","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1021\/jm030026b","article-title":"Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents.","volume":"46","author":"Mathis","year":"2003","journal-title":"J Med Chem"},{"key":"R43-7-20210130","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1093\/brain\/awn016","article-title":"Postmortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimers disease.","volume":"131","author":"Ikonomovic","year":"2008","journal-title":"Brain"},{"key":"R44-7-20210130","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1093\/brain\/awm191","article-title":"PIB is a nonspecific imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosis.","volume":"130","author":"Lockhart","year":"2007","journal-title":"Brain"},{"key":"R45-7-20210130","first-page":"593","article-title":"Electron micrograph of diffuse plaques. Initial stage of senile plaque formation in the Alzheimer brain.","volume":"135","author":"Yamaguchi","year":"1989","journal-title":"Am J Pathol"},{"key":"R46-7-20210130","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1750-3639.2005.tb00103.x","article-title":"Neurovascular pathways and Alzheimer amyloid beta-peptide.","volume":"15","author":"Zlokovic","year":"2005","journal-title":"Brain Pathol"},{"key":"R47-7-20210130","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1073\/pnas.0805453106","article-title":"Selective targeting of perivascular macrophages for clearance of beta-amyloid in cerebral amyloid angiopathy.","volume":"106","author":"Hawkes","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R48-7-20210130","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.neuint.2003.11.006","article-title":"Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology.","volume":"45","author":"Abbott","year":"2004","journal-title":"Neurochem Int"},{"key":"R49-7-20210130","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00401-009-0522-3","article-title":"Neurovascular mechanisms and blood-brain barrier disorder in Alzheimers disease.","volume":"118","author":"Bell","year":"2009","journal-title":"Acta Neuropathol"},{"key":"R50-7-20210130","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2990.2007.00926.x","article-title":"Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology.","volume":"34","author":"Carare","year":"2008","journal-title":"Neuropathol Appl Neurobiol"},{"key":"R51-7-20210130","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11065-007-9031-0","article-title":"Neurocognitive effects of methamphetamine: a critical review and meta-analysis.","volume":"17","author":"Scott","year":"2007","journal-title":"Neuropsychol Rev"},{"key":"R53-7-20210130","doi-asserted-by":"crossref","first-page":"14968","DOI":"10.1073\/pnas.1107411108","article-title":"Serotonin signaling is associated with lower amyloid- levels and plaques in transgenic mice and humans.","volume":"108","author":"Cirrito","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R54-7-20210130","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/sti.76.6.443","article-title":"Cerebrospinal fluid tau concentrations in HIV infected patients with suspected neurological disease.","volume":"76","author":"Green","year":"2000","journal-title":"Sex Transm Infect"},{"key":"R55-7-20210130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3940(98)00549-7","article-title":"Cerebrospinal fluid tau protein is not elevated in HIV-associated neurologic disease in humans. HIV Neurobehavioral Research Center Group (HNRC).","volume":"254","author":"Ellis","year":"1998","journal-title":"Neurosci Lett"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/QAD.0b013e32835a117c","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T20:50:19Z","timestamp":1714423819000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-201211280-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,28]]},"references-count":52,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e32835a117c","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11,28]]}}}